To exclude that the 14.G2a reactivity of Ewing sarcoma cell lines was due to CD166 rather than GD2 expression, as suggested in one report (Wierzbicki et al, 2008), we performed additional staining experiments with the CD166-specific mAb 1172. Here, ALCAM is linked to Ewing sarcoma.